Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
112.5 GBX | 0.00% | +4.65% | +3.69% |
Apr. 25 | EARNINGS AND TRADING: ECO Animal revenue up; Zephyr starts drilling | AN |
Apr. 25 | Eco Animal Health Group plc Provides Earnings Guidance for the Year 2024 | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company is in a robust financial situation considering its net cash and margin position.
- The company shows low valuation levels, with an enterprise value at 0.65 times its sales.
- The company's share price in relation to its net book value makes it look relatively cheap.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- With an expected P/E ratio at 48.64 and 39.06 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.69% | 95.65M | C | ||
-15.35% | 76.23B | B+ | ||
-9.19% | 6.67B | B- | ||
+24.75% | 3.7B | B- | ||
-1.11% | 3.21B | B- | ||
+6.08% | 1.52B | - | ||
-15.13% | 1.37B | B | ||
-25.63% | 1.24B | C- | ||
-7.62% | 1.21B | - | ||
-10.84% | 1.17B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- EAH Stock
- Ratings ECO Animal Health Group plc